Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “United Therapeutics Corporation”

95 pharma patents match "United Therapeutics Corporation" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 95
Index total 30,257
Page 3 / 4

Quick answer

This filtered view shows 95 pharmaceutical patents matching "United Therapeutics Corporation" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

95 results for “United Therapeutics Corporation” · 30,257 patents in full index Clear search

  1. US 9701611

    Salts of treprostinil

    United Therapeutics Corporation · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted
  2. US 9624156

    Compounds and methods for delivery of prostacyclin analogs

    United Therapeutics Corporation · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted
  3. US 9604901

    Process to prepare treprostinil, the active ingredient in Remodulin®

    United Therapeutics Corporation · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted
  4. US 9593066

    Process to prepare treprostinil, the active ingredient in remodulin®

    United Therapeutics Corporation · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  5. US 9422223

    Compounds and methods for delivery of prostacyclin analogs

    United Therapeutics Corporation · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted
  6. US 9387214

    Method of identifying therapies for pulmonary hypertension

    United Therapeutics Corporation · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted
  7. US 9358240

    Treprostinil administration by inhalation

    United Therapeutics Corporation · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  8. US 9339507

    Treprostinil administration by inhalation

    United Therapeutics Corporation · Granted May 17, 2016 · Expires May 12, 2036

    granted
  9. US 9327031

    Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same

    United Therapeutics Corporation · Granted May 3, 2016 · Expires Apr 28, 2036

    granted
  10. US 9278901

    Compounds and methods for delivery of prostacyclin analogs

    United Therapeutics Corporation · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  11. US 9199908

    Compounds and methods for delivery of prostacyclin analogs

    United Therapeutics Corporation · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  12. US 9156786

    Process to prepare treprostinil, the active ingredient in remodulin®

    United Therapeutics Corporation · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  13. US 9102660

    Process of making prostacyclin compounds with linker thiol and pegylated forms

    United Therapeutics Corporation · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted
  14. US 9089515

    Long chain N-alkyl compounds and oxa-derivatives thereof

    United Therapeutics Corporation · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted
  15. US 9050311

    Compounds and methods for delivery of prostacyclin analogs

    United Therapeutics Corporation · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  16. US 9044470

    Iminosugars and methods of treating viral diseases

    United Therapeutics Corporation · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  17. US 8969409

    Treatment for pulmonary hypertension

    United Therapeutics Corporation · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  18. US 8765813

    Use of treprostinil to treat and prevent ischemic lesions

    United Therapeutics Corporation · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  19. US 8748657

    Process to prepare treprostinil

    United Therapeutics Corporation · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted
  20. US 8748460

    Iminosugars and methods of treating togaviral diseases

    United Therapeutics Corporation · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted
  21. US 8658694

    Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same

    United Therapeutics Corporation · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  22. US 8652512

    Nebulized liposomes for the pulmonary application of drug compounds

    United Therapeutics Corporation · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  23. US 8653137

    Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same

    United Therapeutics Corporation · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  24. US 8609728

    Treatment for pulmonary hypertension

    United Therapeutics Corporation · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted